跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,710 条关于
“Beijing Pearl Biotechnology”
全部
7,710
临床试验
1,974
药物
1,060
机构
349
资讯
4,327
去年
Pipeline Analysis Reveals 20+ Drug Candidates for c-MET+ NSCLC Treatment
去年
PEARL Study: Durvalumab Monotherapy Shows Promise in NSCLC Patients with High PD-L1 Expression
去年
Pearl Achieves Historic FDA Clearance for First AI Platform Supporting Both 2D and 3D Dental Imaging Analysis
10个月前
AstraZeneca Establishes Sixth Global R&D Center in Beijing to Accelerate AI-Driven Drug Discovery
2个月前
China's Pharma Industry Charts Innovation-Driven Future at Landmark Beijing Conference
去年
AstraZeneca Invests $2.5 Billion in Beijing to Establish Sixth Global R&D Center
去年
BeOne Medicines Expands Beijing R&D Center to Accelerate Oncology Drug Development
去年
Hanmi's BH3120 Shows Promise in Phase 1 Trials for Advanced Solid Tumors
去年
Hanmi's BH3120 Shows Promise in Early Clinical Trials for Advanced Solid Tumors
去年
Hanmi Pharmaceutical Advances BH3120 Immunotherapy Trials Targeting Solid Tumors
第 1 页，共 433 页
上一页
下一页
